Key result
Therapies targeting cardiomyocyte metabolism have the potential to complement current heart failure treatments by improving the energetic status of the failing heart.
Population
Patients with heart failure (including reduced and preserved ejection fraction)
Design
Review
Authors
Loading...
Metabolic therapies should not yet alter HF management; leaves open their adjunctive potential pending prospective trials.
This review highlights the potential of targeting cardiac metabolism as a complementary approach to current heart failure treatments.
Heggermont et al. (2016) conducted a review in Heart failure. Metabolic therapies was evaluated. Therapies targeting cardiomyocyte metabolism have the potential to complement current heart failure treatments by improving the energetic status of the failing heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: